Journal
JOURNAL OF DRUG TARGETING
Volume 26, Issue 8, Pages 617-632Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/1061186X.2017.1400553
Keywords
Cancer; metal nanoparticles; anticancer drugs; targeting
Categories
Ask authors/readers for more resources
Metal nanoparticles (NPs) may have the potential to overcome problems related to conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in cancer therapy providing better targeting, gene silencing and drug delivery. Functionalised metal NPs with targeting ligands offer a better control of energy deposition in the tumours. Apart from therapeutic benefits, metal NPs are also used as a diagnostic tool for the imaging of cancer cells. Metal NP-based therapeutic systems not only provide simultaneous diagnostic and therapy but also allow controlled and targeted drug release which helps to revolutionise cancer treatment and management. This review addresses the advancement of metal NPs in tumour therapy with a focus on those being explained into clinical settings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available